Trial Condition(s):

Dermatitis, Atopic

An observational study investigating the treatment satisfaction of atopic dermatitis patients who have switched to ointment (W/O emulsion) formulation of Very Strong Class topical corticosteroids (Ointment TS-AD)

Bayer Identifier:

18690

ClinicalTrials.gov Identifier:

NCT02627989

EudraCT Number:

Not Available

Study Completed

Trial Purpose

This study intends to investigate patient satisfaction of treatment with Ointment (W/O emulsion) formulations of Potency Class II topical corticosteroids (TCs) for atopic dermatitis (AD) patients in Japan. Objectives include measuring patient satisfaction, treatment adherence, itchiness, and AD severity scores.

Inclusion Criteria
-Female and male patients with a diagnosis of atopic dermatitis who are treated with Fatty Ointment Potency Class II (Very strong class) TCs
-Patients who are scheduled to change the formulation of the Potency Class II TC from Fatty Ointment to Ointment (Water in Oil; Water per Oil emulsion) as per investigator’s routine treatment practice
-Patients who are aged over 20
-Patients who are able to understand and sign a written informed consent
Exclusion Criteria
-Patients participating in an investigational program with interventions outside of routine clinical practice
 --Patients with any contraindication to TCs
 --Patients who are regarded as ineligible by the investigator
 --Patients who are pregnant or breastfeeding
 --For Period 2 (Spring-Summer), patients enrolled in the Period 1

Trial Summary

Enrollment Goal
55
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Diflucortolone valerate (BAY866146)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Tsu, Japan, 514-8507

Status
Completed
 

Trial Design